Overview
CILICANT OXYGEN ABSORBERS hold a Type III DMF with the USFDA and are manufactured in a cleanroom which qualifies them to be safely used in extending the shelf life of pharmaceutical formulations.
Pharmaceutical formulations exposed to oxidative degradation lose potency because of changes in their molecular structure. The oxidation of molecular structure attached to hydroxyl group may result in colour changes, odour generation and other by-products with adverse pharmacological effects. When pharmaceuticals are not protected from oxidation, they lose efficacy and have a reduced shelf life.